Regeneron Pharmaceuticals (REGN) EPS (2010 - 2026)
Regeneron Pharmaceuticals (REGN) EPS from Jun 30, 2010 to Mar 31, 2026. The TTM Regeneron Pharmaceuticals (REGN) EPS is $41.90. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Regeneron Pharmaceuticals (REGN) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +3.30% |
| 3 Years TTM | +7.23% |
| 5 Years TTM | +5.11% |
| 10 Years TTM | +20.06% |
Annual EPS change of Regeneron Pharmaceuticals (REGN)
| Year | EPS | Change |
|---|---|---|
| 2026 | $6.99 | -83.76% |
| 2025 | $43.07 | +5.31% |
| 2024 | $40.90 | +10.37% |
| 2023 | $37.05 | -8.53% |
| 2022 | $40.51 | -46.98% |
| 2021 | $76.40 | +133.99% |
| 2020 | $32.65 | +68.52% |
| 2019 | $19.38 | -14.47% |
| 2018 | $22.65 | +100.93% |
| 2017 | $11.27 | +31.82% |
| 2016 | $8.55 | +38.58% |
| 2015 | $6.17 | +83.64% |
| 2014 | $3.36 | -20.46% |
| 2013 | $4.23 | -46.67% |
| 2012 | $7.92 | -424.06% |
| 2011 | -$2.45 | +104.19% |
| 2010 | -$1.20 | +39.23% |
| 2009 | -$0.86 | N/A |
Comparison Regeneron Pharmaceuticals (REGN) five years EPS CAGR with competitors
Regeneron Pharmaceuticals (REGN) five years EPS CAGR is 20.31%.